Oct 29, 2026 4:05pm EDT Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial
Oct 15, 2026 8:05am EDT Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
Aug 25, 2026 8:30am EDT Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
Aug 21, 2026 8:30am EDT Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
Aug 17, 2026 8:30am EDT Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Aug 11, 2026 4:05pm EDT Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
Aug 05, 2026 8:30am EDT Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
May 13, 2026 4:05pm EDT Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
Apr 02, 2026 8:30am EDT Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
Mar 26, 2026 5:15pm EDT Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
